miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 237-243

  Shi, Jia Ang ^a   Lu, Da Lin ^b   Huang, Xuan ^c   Tan, Wei ^b  

^a SICHUAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Medical College Nanchang Univerersity   (China)

Author keywords

CD164; Medulloblastoma; microRNA 219; OTX2

Indexed keywords

CD164 ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 219; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CD164 PROTEIN, HUMAN; MIRN219 MICRORNA, HUMAN; OTX2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OTX;

3' UNTRANSLATED REGION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANTIGENS, CD164; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; MICRORNAS; MOLECULAR SEQUENCE DATA; OTX TRANSCRIPTION FACTORS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84902685395     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1749     Document Type: Article

References (22)

1. Esteller M: Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874, 2011.
2. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a rolein cancer. Nat Rev Cancer 6: 259-269, 2006.
3. Crawford JR, MacDonald TJ and Packer RJ: Medulloblastoma in childhood: new biological advances. Lancet Neurol 6: 1073-1085, 2007. (Pubitemid 350116703)
4. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17: 832-845, 1999. (Pubitemid 29109313)
5. Doyonnas R, Yi-Hsin Chan J, Butler LH, et al: CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 165: 840-851, 2000. (Pubitemid 30484751)
6. Tang J, Zhang L, She X, et al: Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest 30: 380-389, 2012.
7. Havens AM, Jung Y, Sun YX, et al: The role of sialomucin CD164 (MGC-24v orendolyn) in prostate cancer metastasis. BMC Cancer 6: 195, 2006.
8. Adamson DC, Shi Q, Wortham M, et al: OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res 70: 181-191, 2010.
9. Luo XG, Zou JN, Wang SZ, Zhang TC and Xi T: Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells. IUBMB Life 62: 194-199, 2010.
10. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and down-regulated geneexpression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574, 2003. (Pubitemid 37204856)
11. Sethupathy P, Megraw M and Hatzigeorgiou AG: A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886, 2006. (Pubitemid 44614721)
12. Venkataraman S, Alimova I, Fan R, et al: MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One 5: e10748, 2010.
13. Weeraratne SD, Amani V, Teider N, et al: Pleiotropic effects of miR-183-96-182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 123: 539-552, 2012.
14. Garzia L1, Andolfo I, Cusanelli E, et al: MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One4: e4998, 2009.
15. Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, Pomeroy SL, Kemkemer R, Witt O, Korshunov A, Lichter P and Pfister SM: MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol 123: 529-538, 2012.
16. Venkataraman S, Birks DK, Balakrishnan I, Alimova I, Harris PS, Patel PR, Handler MH, Dubuc A, Taylor MD, Foreman NK and Vibhakar R: MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem 288: 1918-1928, 2013.
17. Grunder E, D'Ambrosio R, Fiaschetti G, Abela L, Arcaro A, Zuzak T, Ohgaki H, Lv SQ, Shalaby T and Grotzer M: MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer 47: 2479-2490, 2011.
18. Li KK, Pang JC, Lau KM, Zhou L, Mao Y, Wang Y, Poon WS and Ng HK: MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol 23: 413-425, 2013.
19. Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, Zhou L, Chen Z and Ng HK: miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243, 2009.
20. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT and Barres BA: Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65: 597-611, 2010.
21. Huang N, Lin J, Ruan J, Su N, Qing R, Liu F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett 586: 884-891, 2012.
22. Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, Di Rocco C, Riccardi R, Giangaspero F, Farcomeni A, Nofroni I, Laneve P, Gioia U, Caffarelli E, Bozzoni I, Screpanti I and Gulino A: MicroRNA profiling in human MB. Int J Cancer 124: 568-577, 2009.